1.
Chem Commun (Camb)
; 59(93): 13859-13862, 2023 Nov 21.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37929833
RESUMEN
The outer mycomembrane of Mycobacterium tuberculosis and related pathogens is a robust permeability barrier that protects against antibiotic treatment. Here, we demonstrate that synthetic analogues of the mycomembrane biosynthetic precursor trehalose monomycolate bearing truncated lipid chains increase permeability of Mycobacterium smegmatis cells and sensitize them to treatment with the first-line anti-tubercular drug rifampicin. The reported strategy may be useful for enhancing entry of drugs and other molecules to mycobacterial cells, and represents a new way to study mycomembrane structure and function.
Asunto(s)
Mycobacterium tuberculosis , Rifampin , Rifampin/farmacología , Membrana Celular/química , Pared Celular , Mycobacterium tuberculosis/química , Lípidos/análisis
2.